Venous Thromboembolism in Patients Having Knee Replacement and Receiving Thromboprophylaxis
- 20 July 2011
- journal article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 93 (14) , 1281-1287
Abstract
Hromboprophylaxis performed in Denmark from 1997 to 2007. The outcome was hospitalization with symptomatic venous thromboembolism within ninety days of surgery. We examined several potential patient and surgery-related predictors for venous thromboembolism using Cox regression analyses. Results: The overall rate of hospitalization for venous thromboembolism among 37,223 patients within ninety days after primary knee arthroplasty was 1.2% (441 patients) at a median of fifteen days. The rate of hospitalization was 0.9% (323 patients) for deep venous thrombosis and 0.3% (127 patients) for pulmonary embolism, with nine patients who had both. The rate of venous thromboembolism increased during the ten-year study period. Patients with a high score on the Charlson comorbidity index had an increased relative risk for venous thromboembolism compared with patients with a low score (adjusted relative risk = 1.73; 95% confidence interval, 1.24 to 2.41). Patients with a history of cardiovascular disease or a previous venous thromboembolism had an increased risk for postoperative venous thromboembolism compared with patients without these conditions. Surgery-related factors were not predictors for venous thromboembolism. Conclusions: Despite pharmacological thromboprophylaxis, patients undergoing knee arthroplasty remain susceptible for venous thromboembolism events after surgery. Future efforts should focus on the improvement of prophylaxis following hospital discharge, particularly among elderly patients and those with a history of cardiovascular diseases or previous venous thromboembolism. Level of Evidence: Prognostic Level II. See Instructions to Authors for a complete description of levels of evidence....Keywords
This publication has 45 references indexed in Scilit:
- Traditional versus marginal structural models to estimate the effectiveness of β‐blocker use on mortality after myocardial infarctionPharmacoepidemiology and Drug Safety, 2008
- Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based studyInternational Orthopaedics, 2008
- Risk factors for cardiovascular complications following total joint replacement surgeryArthritis & Rheumatism, 2008
- Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgeryCanadian Medical Association Journal, 2008
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Journal of Bone and Joint Surgery, 2007
- Frequency and timing of clinical venous thromboembolism after major joint surgeryThe Journal of Bone and Joint Surgery. British volume, 2006
- Venous thromboembolism associated with hip and knee replacement over a ten-year periodThe Journal of Bone and Joint Surgery. British volume, 2005
- Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee ReplacementNew England Journal of Medicine, 2003
- Incidence and natural history of deep-vein thrombosis after total knee arthroplasty: A prospective, randomised studyThe Journal of Bone and Joint Surgery. British volume, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987